Can proton pump inhibitors increase the risk of sudden unexpected death in Parkinson's disease (SUDPAR)?
作者信息
Menezes-Rodrigues Francisco Sandro, Tallo Fernando Sabia, Caricati-Neto Afonso, Finsterer Josef, Scorza Carla Alessandra, Scorza Fulvio Alexandre
机构信息
Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.
Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.
出版信息
Clinics (Sao Paulo). 2025 Jul 31;80:100721. doi: 10.1016/j.clinsp.2025.100721.
Abstract
摘要
相似文献
1
Can proton pump inhibitors increase the risk of sudden unexpected death in Parkinson's disease (SUDPAR)?质子泵抑制剂会增加帕金森病患者意外猝死（SUDPAR）的风险吗？
Clinics (Sao Paulo). 2025 Jul 31;80:100721. doi: 10.1016/j.clinsp.2025.100721.
2
Sudden unexpected death in Parkinson's disease: Insights from clinical practice.帕金森病患者的突然意外死亡：来自临床实践的见解。
Clinics (Sao Paulo). 2022 Feb 10;77:100001. doi: 10.1016/j.clinsp.2021.100001. eCollection 2022.
3
Sudden death in Parkinson's disease: Unjustifiably forgotten.帕金森病猝死：被不合理地遗忘。
Parkinsonism Relat Disord. 2019 Jan;58:88-89. doi: 10.1016/j.parkreldis.2018.08.012. Epub 2018 Aug 30.
4
Sudden unexpected death in Parkinson's disease (SUDPAR): a review of publications since the decade of the brain.帕金森病猝死（SUDPAR）：自脑科学十年以来的出版物综述
Clinics (Sao Paulo). 2017 Nov;72(11):649-651. doi: 10.6061/clinics/2017(11)01.
5
Sudden Unexpected Death in Parkinson's Disease (SUDPAR): a fatal event that James Parkinson did not address.帕金森病猝死（SUDPAR）：詹姆斯·帕金森未涉及的致命事件。
Age Ageing. 2018 Jul 1;47(4):627. doi: 10.1093/ageing/afy064.
6
Sudden unexpected death in Parkinson's disease (SUDPAR): sleep apnea increases risk of heart attack.帕金森病猝死（SUDPAR）：睡眠呼吸暂停会增加心脏病发作风险。
Sleep Breath. 2017 Dec;21(4):965-966. doi: 10.1007/s11325-017-1511-8. Epub 2017 May 23.
7
Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.重症监护病房患者上消化道出血的预防干预措施。
Cochrane Database Syst Rev. 2018 Jun 4;6(6):CD008687. doi: 10.1002/14651858.CD008687.pub2.
8
Association between Parkinson's disease and proton pump inhibitors therapy in older people.老年人帕金森病与质子泵抑制剂治疗之间的关联。
Biomedicine (Taipei). 2020 Sep 1;10(3):1-4. doi: 10.37796/2211-8039.1048. eCollection 2020.
9
SGLT2 inhibitors vs. metformin for Parkinson's disease risk reduction in type 2 diabetes.钠-葡萄糖协同转运蛋白2抑制剂与二甲双胍对2型糖尿病患者帕金森病风险的降低作用比较
J Parkinsons Dis. 2025 Jul 17:1877718X251359391. doi: 10.1177/1877718X251359391.
10
Psychosis in early onset Parkinson's disease: A retrospective cohort study in southeast Minnesota.早发性帕金森病中的精神病：明尼苏达州东南部的一项回顾性队列研究。
J Parkinsons Dis. 2025 Jun 30:1877718X251354978. doi: 10.1177/1877718X251354978.
本文引用的文献
1
[Drug Therapy for Gastroesophageal Reflux Disease].[胃食管反流病的药物治疗]
Korean J Gastroenterol. 2025 Apr 25;85(2):146-152. doi: 10.4166/kjg.2024.145.
2
Use of pulse pressure index for cardiovascular outcomes assessment and development of a coronary heart disease model for the elderly.脉搏压指数在心血管结局评估中的应用及老年冠心病模型的建立。
BMC Cardiovasc Disord. 2025 Apr 18;25(1):297. doi: 10.1186/s12872-025-04641-8.
3
Comparison of Potassium-Competitive Acid Blockers and Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.钾离子竞争性酸阻滞剂与质子泵抑制剂治疗胃食管反流病患者的比较：一项随机对照试验的系统评价和荟萃分析
Cureus. 2024 Jul 22;16(7):e65141. doi: 10.7759/cureus.65141. eCollection 2024 Jul.
4
Widespread use of proton pump inhibitors or potassium-competitive acid blocker has changed the status of gastrointestinal bleeding in patients with ischemic heart disease: real-world data from high volume centers.质子泵抑制剂或钾竞争性酸阻滞剂的广泛应用改变了缺血性心脏病患者胃肠道出血的状况：来自大容量中心的真实世界数据。
BMC Gastroenterol. 2024 May 21;24(1):177. doi: 10.1186/s12876-024-03269-w.
5
Cardiotoxic Effects Produced by Omeprazole and Methylene Blue in an Animal Model of Cardiac Ischemia and Reperfusion and Potential Implications for the Pharmacological Strategy for Vasoplegic Syndrome.奥美拉唑和亚甲蓝在心脏缺血再灌注动物模型中产生的心脏毒性作用及其对血管麻痹综合征药理学策略的潜在影响
Biomedicines. 2024 Mar 6;12(3):582. doi: 10.3390/biomedicines12030582.
6
Role of cardiac β-adrenergic and A-adenosine receptors in severe arrhythmias related to Parkinson's disease.心脏β-肾上腺素能和 A-腺苷受体在帕金森病相关严重心律失常中的作用。
Clinics (Sao Paulo). 2023 Jul 15;78:100243. doi: 10.1016/j.clinsp.2023.100243. eCollection 2023.
7
The pharmacotherapeutic management of gastroesophageal reflux disease (GERD).胃食管反流病（GERD）的药物治疗管理
Expert Opin Pharmacother. 2021 Feb;22(2):219-227. doi: 10.1080/14656566.2020.1817385. Epub 2020 Sep 7.
8
Sudden unexpected death in Parkinson's disease: why is drinking water important?帕金森病中的意外猝死：为什么饮水很重要？
Neurodegener Dis Manag. 2019 Aug;9(4):241-246. doi: 10.2217/nmt-2019-0010. Epub 2019 Aug 13.
9
Association of histamine with hypertension-induced cardiac remodeling and reduction of hypertrophy with the histamine-2-receptor antagonist famotidine compared with the beta-blocker metoprolol.组胺与高血压诱导的心脏重构的关系，以及与β受体阻滞剂美托洛尔相比，组胺-2 受体拮抗剂法莫替丁对肥厚的抑制作用。
Hypertens Res. 2018 Dec;41(12):1023-1035. doi: 10.1038/s41440-018-0109-2. Epub 2018 Oct 11.
10
Cardiac abnormalities in Parkinson's disease and Parkinsonism.帕金森病和帕金森综合征中的心脏异常。
J Clin Neurosci. 2018 Jul;53:1-5. doi: 10.1016/j.jocn.2018.04.031. Epub 2018 Apr 26.
Zotero 插件